InvestorsHub Logo
Followers 237
Posts 10817
Boards Moderated 0
Alias Born 07/17/2006

Re: north40000 post# 60630

Monday, 10/05/2015 8:54:26 AM

Monday, October 05, 2015 8:54:26 AM

Post# of 425975
North...

I also do not understand your argument.

Amarin's "promotions" do not include statements like R-I has shown V lowers CVD risk...statements which would require a positive result from the trial..What they include are results of completed trials..eg.JELIS, as well as clinical, physiological, and epidemiological information that supports the utility of EPA (Vascepa) in adequate dosage to lower CVD risk.

Holding off until the R-I results are known is a terrible idea.

":>) JL

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News